News

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was quickly hyped online as the secret to celebrities achieving extreme thinness.
I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and world-changing—that ...
Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company. Adrian, a ...
Retail chatter around WW International surged Tuesday after the company’s expanded collaboration with Novo Nordisk officially ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.
Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...